Deciphera Pharmaceuticals Secures $75,000,000 Series B Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cafb0ce3-ef59-4fc3-bbe2-371ee40a6379 - Date
9/21/2015 - Company Name
Deciphera Pharmaceuticals - Mailing Address
1601 Trapelo Road Waltham, MA 02451 USA - Company Description
Deciphera Pharmaceuticals, LLC was established in 2003 as a drug discovery and development company with the mission to design, optimize and introduce best-in-class small molecule switch inhibitors of protein kinases for human clinical trials and the global pharmaceutical marketplace through the use of its proprietary drug discovery technology platform. - Website
http://www.deciphera.com - Transaction Type
Venture Equity - Transaction Amount
$75,000,000 - Transaction Round
Series B - Proceeds Purposes
The proceeds will enable Deciphera to advance its pipeline of proprietary switch control kinase inhibitors through multiple key clinical milestones. - M&A Terms
- Venture Investor
New Leaf Venture Partners - Venture Investor
Undisclosed
